PMID: 7030442Aug 1, 1981Paper

Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo

The British Journal of Psychiatry : the Journal of Mental Science
M PeetR A Yates

Abstract

Fifty-three hospitalized chronic schizophrenic patients were treated with either propranolol, chlorpromazine or placebo in a double-blind randomized trials for up to three months. Propranolol in a usual dose of 640 mg/day, produced marked cardiovascular effects but no improvement in schizophrenic symptomatology relative to placebo. The effects of chlorpromazine were small and inconsistent.

References

Nov 5, 1977·Lancet·A P RidgesN Hindson
Jun 1, 1979·Annals of Internal Medicine·E S GershonD P van Kammen
May 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·G P Sheppard
Nov 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·H S Fraser, A C Carr
Jun 8, 1974·Archiv für Psychiatrie und Nervenkrankheiten·W RackenspergerK H Stutte
Aug 1, 1967·The British Journal of Psychiatry : the Journal of Mental Science·J S Hughes, J C Little
Sep 1, 1967·The British Journal of Psychiatry : the Journal of Mental Science·F J Letemendia, A D Harris
Jan 1, 1972·Archives of General Psychiatry·J P FeighnerR Munoz
Aug 1, 1966·Psychological Reports·G HonigfeldC J Klett
Jan 1, 1980·The American Journal of Psychiatry·G Chouinard, B D Jones
Jan 12, 1980·British Medical Journal·T J Crow
Feb 1, 1980·Psychological Medicine·C D Marsden, P Jenner
Aug 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·L H Lindström, E Persson
Jan 1, 1980·Psychopharmacology·N BjørndalJ Gerlach
Nov 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·D J KingC D Kinney
Jan 1, 1981·Acta Psychiatrica Scandinavica·N J YorkstonS R Hirsch
Aug 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·M PeetR A Yates
May 1, 1982·The Medical Journal of Australia·F Judd, A Mass
Feb 23, 1980·The Medical Journal of Australia·F A Whitlock, A R Bonfield
Jun 1, 1980·Archives of General Psychiatry·T HanssenL Wetterberg

❮ Previous
Next ❯

Citations

Jan 1, 1984·Journal of Psychosomatic Research·A J Cooper, R V Magnus
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·B B Sethi, S Dubé
Jan 1, 1987·Progress in Neuro-psychopharmacology & Biological Psychiatry·R Manchanda
Jun 1, 1990·Journal of Neurochemistry·V L Nimgaonkar, S A Whatley
Jan 1, 1991·International Journal of Psychiatry in Medicine·S L RauchR M Zusman
Jan 1, 1997·Journal of Psychopharmacology·F W DeakinJ S Hellewell
Nov 1, 2001·The Cochrane Database of Systematic Reviews·M CheineK Wahlbeck
Jan 8, 2014·The Cochrane Database of Systematic Reviews·Clive E AdamsKarla Soares-Weiser
Jun 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·R Manchanda, S R Hirsch
Aug 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·M PeetR A Yates
Aug 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·C R PughR G Priest
Mar 1, 1983·British Journal of Clinical Pharmacology·D J KingJ Liddle
May 1, 1995·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·D L Streiner
Oct 1, 1990·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·D L Streiner
May 2, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·David L Streiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
D J KingC D Kinney
The Australian and New Zealand Journal of Psychiatry
G Oppenheim
Pharmacology & Toxicology
R Klysner
© 2021 Meta ULC. All rights reserved